American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 39,231 | 23,282 | 9,422 | 43,866 | 28,026 |
| Depreciation Amortization | 7,381 | 4,746 | 2,340 | 5,022 | 2,753 |
| Income taxes - deferred | 898 | 714 | 2,745 | 154 | 246 |
| Accounts receivable | -7,984 | -697 | 2,150 | -4,142 | -3,914 |
| Accounts payable and accrued liabilities | 1,352 | 1,235 | 607 | 629 | 2,162 |
| Other Working Capital | -645 | -1,309 | -4,048 | -4,523 | -4,471 |
| Other Operating Activity | 8,598 | 404 | -2,539 | 4,359 | 2,187 |
| Operating Cash Flow | $48,831 | $28,375 | $10,676 | $45,365 | $26,990 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,503 | -616 | -177 | -3,973 | -1,981 |
| Net Acquisitions | N/A | N/A | N/A | -65,873 | -16,817 |
| Purchase Of Investment | -21,762 | -19,658 | -3,728 | N/A | N/A |
| Purchase Sale Intangibles | -15,408 | -96 | N/A | N/A | N/A |
| Other Investing Activity | -41,880 | -37,838 | -16,448 | 0 | -4,421 |
| Investing Cash Flow | $-84,145 | $-58,111 | $-20,353 | $-69,846 | $-23,219 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 6,584 | N/A | N/A | N/A | 5,999 |
| Debt Issued | 110,359 | 3,525 | 698 | N/A | N/A |
| Debt Repayment | -71 | -10 | -714 | N/A | -12 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 79,481 |
| Other Financing Activity | -36,624 | -3,903 | 0 | 0 | -9,794 |
| Financing Cash Flow | $80,248 | $-388 | $-17 | $N/A | $75,674 |
| Exchange Rate Effect | 8,383 | 8,188 | 2,315 | N/A | 3,395 |
| Beginning Cash Position | 166,410 | 166,410 | 166,410 | N/A | 87,784 |
| End Cash Position | 219,727 | 144,473 | 159,031 | N/A | 170,624 |
| Net Cash Flow | $53,317 | $-21,937 | $-7,379 | $-24,481 | $79,445 |
| Free Cash Flow | |||||
| Operating Cash Flow | 48,831 | 28,375 | 10,676 | 45,365 | 26,990 |
| Capital Expenditure | -20,510 | -616 | -177 | -3,986 | -1,981 |
| Free Cash Flow | 28,321 | 27,759 | 10,499 | 41,379 | 25,009 |